Evidence map›Paper›PMID 39695604›Full record

ArticleBMC health services research2024

Utility of colposcopy for the screening and management of cervical cancer in Africa: a cross-sectional analysis of providers' training and practices.

Joël Fokom Domgue, Issimouha Dille, Freddy Gnangnon, Sharon Kapambwe, Celine Bouchard, Nomonde Mbatani, Elodie Gauroy, Nathalie Ledaga Ambounda, Robert Yu, Fatoumata Sidibe and 11 more

Abstract read
In one paragraph

Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Joël Fokom DomgueDivision of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, 1400 Pressler Dr., FCT4.6002, Houston, TX, 77030, USA.
Issimouha DilleDivision of Non communicable Diseases, World Health Organization Regional Office for Africa, P.O. Box: 06, Brazzaville, Republic of the Congo.
Freddy GnangnonDivision of Surgical Oncology, Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin.
Sharon KapambweDivision of Non communicable Diseases, World Health Organization Regional Office for Africa, P.O. Box: 06, Brazzaville, Republic of the Congo.
Celine BouchardCentre Medical Sante Femmes, Quebec, Canada.
Nomonde MbataniGynecologic Oncology Unit, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Elodie GauroyInstitut Universitaire du Cancer de Toulouse, Toulouse, France.
Nathalie Ledaga AmboundaDepartment of Obstetrics and Gynecology, University Hospital Centre of Libreville, Libreville, Gabon.
Robert YuDivision of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, 1400 Pressler Dr., FCT4.6002, Houston, TX, 77030, USA.
Fatoumata SidibeMedical Oncology Unit, CHU du Point G, Faculty of Medicine and Dentistry, University of Bamako, Bamako, Mali.
Joseph KamgnoDepartment of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaounde, Cameroon.
Bangaly TraoreDivision of Surgical Oncology, Faculty of Health Sciences and Technics, University Gamal Abdel Nasser of Conakry, Conakry, Guinea.
Pierre-Marie TebeuDepartment of Gynecology and Obstetrics, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaounde, Cameroon.
Gregory Halle-EkaneDepartment of Obstetrics and Gynecology, Faculty of Health Sciences, University of Buea, Buea, Cameroon.
Mohenou Isidore DiomandeDepartment of Pathology, University Teaching Hospital of Cocody, Abidjan, Côte d'Ivoire.
Jean-Marie DangouDivision of Non communicable Diseases, World Health Organization Regional Office for Africa, P.O. Box: 06, Brazzaville, Republic of the Congo.
Fabrice LecuruDepartment of Gynecologic and Breast Surgical Oncology, Institut Curie, Paris, France.
Isaac AdewoleDepartment of Obstetrics and Gynecology, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Marie PlanteDivision of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of Laval, Quebec, Canada.
Partha BasuEarly Detection, Prevention and Infections Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.
Sanjay SheteDivision of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, 1400 Pressler Dr., FCT4.6002, Houston, TX, 77030, USA. sshete@mdanderson.org.

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionCervical cancer is a public health issue in Africa with devastating socioeconomic consequences due to the lack of organized screening programs. The success of screening programs depends on the appropriate investigation and management of women who test positive for screening. Colposcopic assessment following positive screening results is a noteworthy issue in Africa. This study aimed to assess the utilization of colposcopy by providers in the region.

methodsA cross-sectional study was conducted in 2021-2022 among healthcare providers involved in cervical cancer prevention activities in Africa. They were invited to report prior colposcopy training, whether they performed colposcopy and the indications of colposcopy in their practice.

resultsOf the 130 providers from 23 African countries who responded to the survey (mean age [SD]: 39.0 years [9.4]), half were female (65 [50.0%]), and 90.7% reported working in urban areas. Overall, only 12.6% of respondents indicated having received prior training on colposcopy, and 11.7% reported that they were performing colposcopy in their current practice. Among the providers who reported performing colposcopy in their practice, colposcopy was indicated for routine cervical cancer screening in 21.2% of clinicians, to better visualize the transformation zone in 15.2% of respondents, to further assess the vascularization of cervical mucosa in 33.3% of respondents, and to determine the appropriate treatment modality in 12.1% of respondents. Providers who performed colposcopy in their practice reported a median number of 30 (interquartile range: 19-65) colposcopic procedures in the past 6 months.

conclusionProviders' training and practice of colposcopy for cervical cancer screening remain suboptimal in Africa. To increase utilization of colposcopy in the region, further training is needed to improve providers' knowledge and engagement. With the development of lower-cost and portable colposcopes, efforts to equip cervical cancer prevention programs and facilities with colposcopy should be enhanced to ensure that women can be screened and managed appropriately in the clinical setting and communities.

Indexed as

ColposcopyEarly Detection of CancerUterine Cervical NeoplasmsAdultAfricaCross-Sectional StudiesFemaleHealth PersonnelHumansMaleMass ScreeningMiddle AgedSurveys and QuestionnairesAfricaCancer preventionCervical cancerCervical cancer screeningColposcopyEarly detectionHealthcare providersSecondary preventionTransformation zoneVisualization

Identifiers

PMID39695604
PMCPMC11658535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.